Search - tctmd.com

Displaying 361 - 376 of 376

Sort: Relevancy | Date

News Daily News

Long-term Safety of PCI vs. CABG for Left Main Disease Depends on Syntax Score

May 16, 2011

News Daily News

Two-Year Data Published from SPIRIT IV, COMPARE: Xience Still Favored Over Taxus

April 20, 2011

News Daily News

Bleeding Increases Mortality as Late as 3 Years After DES

Leah Lawrence

April 18, 2011

News Conference News

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Caitlin E. Cox

April 08, 2011

News Daily News

Pioglitazone Can Decrease Need for Revascularization in Diabetic Patients After BMS

L.A. McKeown

April 07, 2011

News Conference News

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

April 05, 2011

News Conference News

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Caitlin E. Cox

April 04, 2011

News Industry News

Medtronic Resolute® Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies

April 04, 2011

News Industry News

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

April 03, 2011

News Daily News

Stent Thrombosis, Major Bleeding Rare with Sirolimus-Eluting Stents

March 21, 2011

News Daily News

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

March 14, 2011

News Daily News

Studies Support DES Use in Diabetics, But Results Vary by Device

Caitlin E. Cox

March 08, 2011

News Daily News

Superiority of Xience V Over Taxus in Women Sustained at 3 Years

Leah Lawrence

February 03, 2011

News Daily News

More Than 1 in 10 Patients Discontinue Antiplatelet Therapy Early

L.A. McKeown

January 24, 2011

News Daily News

DES Linked with More Stent Thrombosis Than BMS 1 Year After Primary PCI

January 18, 2011

News Daily News

Benefit of Sirolimus Stents Sharply Attenuated in Dialysis Patients

January 04, 2011

Advertisement

Long-term Safety of PCI vs. CABG for Left Main Disease Depends on Syntax Score

Two-Year Data Published from SPIRIT IV, COMPARE: Xience Still Favored Over Taxus

Bleeding Increases Mortality as Late as 3 Years After DES

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Pioglitazone Can Decrease Need for Revascularization in Diabetic Patients After BMS

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Medtronic Resolute® Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

Stent Thrombosis, Major Bleeding Rare with Sirolimus-Eluting Stents

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

Studies Support DES Use in Diabetics, But Results Vary by Device

Superiority of Xience V Over Taxus in Women Sustained at 3 Years

More Than 1 in 10 Patients Discontinue Antiplatelet Therapy Early

DES Linked with More Stent Thrombosis Than BMS 1 Year After Primary PCI

Benefit of Sirolimus Stents Sharply Attenuated in Dialysis Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content